Yep. Further detail in the 'going concern' section of the notes to the consolidated financial statements. Plenty to like imo, particularly if you believe that Beyond Media revenue will destroy the current liabilities next calendar year.
The Directors have prepared a cash flow forecast for the period ending 30 September 2017, which indicates that the Group will have sufficient cash flows to meet all commitments and working capital requirements for the 12 month period from the date of signing this financial report. In particular the Company:
- has negotiated extended credit terms with creditors to the value of $569,370, in that payment won’t be required until sufficient funds have been raised from debt/equity sources or profitability, at which point and appropriate payment plan will be agreed
- the convertible note currently standing at $473,314 associated with the CEO loan, and CFO Loans of $138,122, plus the accruals of the CEO of salary of $118,937 which has not been paid has also been agreed that they will not call the cash unless mutually agreed by board under an agreeable structure to either convert over time or cash over time.
- furthermore the convertible note facility provided by the CEO was extended on 7 April 2016 to 30 June 2017 and there remains $526,686 available for immediate draw down;
- is currently in negotiations for external investment in some of its entities, including Gophr and Boppl, which will result in the company no longer needing to fund the operations of those entities;
- is in negotiations to have a cash ingestion of $2,000,000 (before costs) from either debt or equity funding arrangements by the end of October 2016; and
- Beyond Media is forecast to trade profitably and provide working capital funding for other business segments in the Group by March 2017.
- Forums
- ASX - By Stock
- Ann: Annual Report to shareholders-YNB.AX
Yep. Further detail in the 'going concern' section of the notes...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVC (ASX) to my watchlist
(20min delay)
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.31M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 48150 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.460 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 48150 | 2 |
0.600 | 15000 | 1 |
0.690 | 5200 | 1 |
0.700 | 20000 | 1 |
0.790 | 45037 | 2 |
Last trade - 10.00am 07/05/2024 (20 minute delay) ? |
Featured News
AVC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online